Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.829 USD | +0.36% | +1.00% | -12.94% |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immune-mediated Diseases and Cancer Therapeutics
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 7 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Gitanjali Jain
IRC | Investor Relations Contact | - | 21-10-04 |
Nick Mordwinkin
PRN | Corporate Officer/Principal | - | 22-07-10 |
Li Long
PRN | Corporate Officer/Principal | - | - |
Andrea Fan
PRN | Corporate Officer/Principal | - | 14-12-31 |
Jinhai Wang
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | - | |
General Counsel | - | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 16-10-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
Elizabeth Garner
BRD | Director/Board Member | 56 | 19-12-17 |
Courtney Wallace
BRD | Director/Board Member | 40 | 21-12-08 |
Micki Klearman
BRD | Director/Board Member | 69 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 72,801,359 | 62,021,528 ( 85.19 %) | 0 | 85.19 % |
Company contact information
Kezar Life Sciences, Inc.
4000 Shoreline Court Suite 300
94080, South San Francisco
+650 822 5600
http://www.kezarlifesciences.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.81% | 60.13M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.94% | 22.19B | |
-16.16% | 21.33B | |
-7.35% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- KZR Stock
- Company Kezar Life Sciences, Inc.